Evidence map›Paper›PMID 27237948›Full record

ArticleInfection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2016

Molecular characterization of the first G24P[14] rotavirus strain detected in humans.

M Leanne Ward, Slavica Mijatovic-Rustempasic, Sunando Roy, Kunchala Rungsrisuriyachai, Julie A Boom, Leila C Sahni, Carol J Baker, Marcia A Rench, Mary E Wikswo, Daniel C Payne and 2 more

Abstract readCase Reports
In one paragraph

Article in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

M Leanne WardDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: mrw0@cdc.gov.
Slavica Mijatovic-RustempasicDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: hsr7@cdc.gov.
Sunando RoyDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: sunando@gmail.com.
Kunchala RungsrisuriyachaiDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: Torekunchala@gmail.com.
Julie A BoomTexas Children's Hospital, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA. Electronic address: jaboom@texaschildrens.org.
Leila C SahniTexas Children's Hospital, Houston, TX, USA. Electronic address: lcsahni@texaschildrens.org.
Carol J BakerTexas Children's Hospital, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA. Electronic address: cbaker@bcm.edu.
Marcia A RenchTexas Children's Hospital, Houston, TX, USA; Baylor College of Medicine, Houston, TX, USA. Electronic address: mrench@bcm.edu.
Mary E WikswoDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: ezq1@cdc.gov.
Daniel C PayneDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: dvp6@cdc.gov.
Umesh D ParasharDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: uap2@cdc.gov.
Michael D BowenDivision of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA. Electronic address: mkb6@cdc.gov.
Centers for Disease Control and Prevention · USBaylor College of Medicine · USTexas Children's Hospital · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Here we report the genome of a novel rotavirus A (RVA) strain detected in a stool sample collected during routine surveillance by the Centers for Disease Control and Prevention's New Vaccine Surveillance Network. The strain, RVA/human-wt/USA/2012741499/2012/G24P[14], has a genomic constellation of G24-P[14]-I2-R2-C2-M2-A3-N2-T9-E2-H3. The VP2, VP3, VP7 and NSP3 genes cluster phylogenetically with bovine strains. The other genes occupy mixed clades containing animal and human strains. Strain RVA/human-wt/USA/2012741499/2012/G24P[14] most likely is the product of interspecies transmission and reassortment events. This is the second report of the G24 genotype and the first report of the G24P[14] genotype combination in humans.

Indexed as

Genome, ViralGenotypePhylogenyAnimalsCattleChild, PreschoolHigh-Throughput Nucleotide SequencingHumansMaleReassortant VirusesRotavirusRotavirus InfectionsTexasViral Nonstructural ProteinsViral Nonstructural ProteinsBovineG24P[14]ReassortmentRotavirus

Identifiers

PMID27237948
PMCPMC5072358
OpenAlexW2402777324

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.